Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul 18:7:F1000 Faculty Rev-1104.
doi: 10.12688/f1000research.14634.1. eCollection 2018.

Genetics and epigenetics of pediatric leukemia in the era of precision medicine

Kristie N Ramos  1 , Irma N Ramos  2 , Yi Zeng  3   4 , Kenneth S Ramos  1   4   5
Affiliations
Review

Genetics and epigenetics of pediatric leukemia in the era of precision medicine

Kristie N Ramos et al. F1000Res. .

Abstract

Pediatric leukemia represents a heterogeneous group of diseases characterized by germline and somatic mutations that manifest within the context of disturbances in the epigenetic machinery and genetic regulation. Advances in genomic medicine have allowed finer resolution of genetic and epigenetic strategies that can be effectively used to risk-stratify patients and identify novel targets for therapy. This review discusses the genetic and epigenetic mechanisms of leukemogenesis, particularly as it relates to acute lymphocytic leukemias, the mechanisms of epigenetic control of leukemogenesis, namely DNA methylation, histone modifications, microRNAs, and LINE-1 retroelements, and highlights opportunities for precision medicine therapeutics in further guiding disease management. Future efforts to broaden the integration of advances in genomic and epigenomic science into the practice of pediatric oncology will not only identify novel therapeutic strategies to improve clinical outcomes but also improve the quality of life for this unique patient population. Recent findings in precision therapeutics of acute lymphocytic leukemias over the past three years, along with some provocative areas of epigenetics research, are reviewed here.

Keywords: Epigenetics; Pediatric Leukemia; Precision Medicine.

PubMed Disclaimer

Conflict of interest statement

No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed.

Similar articles

See all similar articles

Cited by

References

    1. Brisson GD, Alves LR, Pombo-de-Oliveira MS: Genetic susceptibility in childhood acute leukaemias: a systematic review. Ecancermedicalscience. 2015;9:539. 10.3332/ecancer.2015.539 - DOI - PMC - PubMed

    2. F1000 Recommendation

    1. Ward E, DeSantis C, Robbins A, et al. : Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83–103. 10.3322/caac.21219 - DOI - PubMed
    1. Mullighan CG, Zhang J, Kasper LH, et al. : CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature. 2011;471(7337):235–9. 10.1038/nature09727 - DOI - PMC - PubMed

    2. F1000 Recommendation

    1. Hunger SP, Mullighan CG: Acute Lymphoblastic Leukemia in Children. N Engl J Med. 2015;373(16):1541–52. 10.1056/NEJMra1400972 - DOI - PubMed

    2. F1000 Recommendation

    1. Nordlund J, Syvänen A: Epigenetics in pediatric acute lymphoblastic leukemia. Semin Cancer Biol. 2017. 10.1016/j.semcancer.2017.09.001 - DOI - PubMed

    2. F1000 Recommendation

LinkOut - more resources